Brought to you by 
Syntropharma completes £1.25mm Series B financing
23 Sep 2008
Executive Summary
Scottish transdermal drug delivery company Syntropharma raised £1.25mm ($2.4mm) in its Series B financing, which included Scottish Enterprise's Co-Investment Fund, Highland Venture Capital, LINC, Balmoral, ChimaeraBio, and Tweed Renaissance Investors Capital (TRI Cap).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Transdermal
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com